Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.24+0.22 (+0.31%)
Close on Nov 18, 2026Market cap $230.00MP/E 22.0Yield –
Utah Medical Products revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Utah Medical Products's revenue for the twelve months ending Jun 30, 2026 was $36.11M. For fiscal 2025 it was $38.52M, down 5.8% from the year before. Over ten years it grew -0.4% a year on average. The highest annual figure on record is $52.28M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.52M | -5.8% |
| FY2024 | Dec 31, 2024 | $40.90M | -18.6% |
| FY2023 | Dec 31, 2023 | $50.22M | -3.9% |
| FY2022 | Dec 31, 2022 | $52.28M | +6.6% |
| FY2021 | Dec 31, 2021 | $49.05M | +16.3% |
| FY2020 | Dec 31, 2020 | $42.18M | -10.1% |
| FY2019 | Dec 31, 2019 | $46.90M | +11.7% |
| FY2018 | Dec 31, 2018 | $42.00M | +1.4% |
| FY2017 | Dec 31, 2017 | $41.41M | +5.4% |
| FY2016 | Dec 31, 2016 | $39.30M | -2.1% |
| FY2015 | Dec 31, 2015 | $40.16M | -2.7% |
| FY2014 | Dec 31, 2014 | $41.28M | +1.9% |
| FY2013 | Dec 31, 2013 | $40.49M | -2.5% |
| FY2012 | Dec 31, 2012 | $41.55M | +9.8% |
| FY2011 | Dec 31, 2011 | $37.86M | +50.7% |
| FY2010 | Dec 31, 2010 | $25.12M | -3.1% |
| FY2009 | Dec 31, 2009 | $25.92M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.53M | -14.3% |
| Q1 FY2026 | Mar 31, 2026 | $8.72M | -10.2% |
| Q4 FY2025 | Dec 31, 2025 | $9.04M | -26.7% |
| Q3 FY2025 | Sep 30, 2025 | $9.81M | -21.5% |
| Q2 FY2025 | Jun 30, 2025 | $9.95M | -22.6% |
| Q1 FY2025 | Mar 31, 2025 | $9.71M | -22.4% |
| Q4 FY2023 | Dec 31, 2023 | $12.33M | -9.1% |
| Q3 FY2023 | Sep 30, 2023 | $12.51M | -3.5% |
| Q2 FY2023 | Jun 30, 2023 | $12.87M | -4.2% |
| Q1 FY2023 | Mar 31, 2023 | $12.52M | +1.6% |
| Q4 FY2022 | Dec 31, 2022 | $13.58M | +5.1% |
| Q3 FY2022 | Sep 30, 2022 | $12.96M | +3.0% |
| Q2 FY2022 | Jun 30, 2022 | $13.43M | +6.5% |
| Q1 FY2022 | Mar 31, 2022 | $12.32M | +12.4% |
| Q4 FY2021 | Dec 31, 2021 | $12.91M | +7.5% |
| Q3 FY2021 | Sep 30, 2021 | $12.57M | +20.0% |
| Q2 FY2021 | Jun 30, 2021 | $12.60M | +43.4% |
| Q1 FY2021 | Mar 31, 2021 | $10.96M | +0.6% |
| Q4 FY2020 | Dec 31, 2020 | $12.01M | +1.5% |
| Q3 FY2020 | Sep 30, 2020 | $10.48M | -16.1% |
| Q2 FY2020 | Jun 30, 2020 | $8.79M | -25.8% |
| Q1 FY2020 | Mar 31, 2020 | $10.90M | +1.6% |
| Q4 FY2019 | Dec 31, 2019 | $11.83M | +21.3% |
| Q3 FY2019 | Sep 30, 2019 | $12.49M | +20.3% |
| Q2 FY2019 | Jun 30, 2019 | $11.85M | +8.0% |
| Q1 FY2019 | Mar 31, 2019 | $10.73M | -1.4% |
| Q4 FY2018 | Dec 31, 2018 | $9.76M | -4.4% |
| Q3 FY2018 | Sep 30, 2018 | $10.39M | +2.6% |
| Q2 FY2018 | Jun 30, 2018 | $10.97M | +1.3% |
| Q1 FY2018 | Mar 31, 2018 | $10.89M | +6.1% |
| Q4 FY2017 | Dec 31, 2017 | $10.20M | +15.2% |
| Q3 FY2017 | Sep 30, 2017 | $10.13M | +4.9% |
| Q2 FY2017 | Jun 30, 2017 | $10.83M | +3.2% |
| Q1 FY2017 | Mar 31, 2017 | $10.26M | -0.4% |
| Q4 FY2016 | Dec 31, 2016 | $8.85M | -7.6% |
| Q3 FY2016 | Sep 30, 2016 | $9.66M | – |
| Q2 FY2016 | Jun 30, 2016 | $10.49M | – |
| Q1 FY2016 | Mar 31, 2016 | $10.30M | – |
| Q4 FY2015 | Dec 31, 2015 | $9.58M | – |
See a number that looks wrong?